It was the second part of "The Trader" column". To summarize the stock was recommended in this column back in Sep 2015 and was a followup. Bank stocks generally down and BBT is boring but could still give a double digit return this year. BBT's business is doing well. Stock down on microeconomic concernes not the about BBT's business. $206M increase in energy related non performing loans however total energy loans are $1.6B out of $134B total loans. BBT just bought a bunch of banks while investors are disenchanted with M&A in banking. Management is committed to "peer leading" dividend so another increase in 3rd quarter is possible. The 2016 EPS estimate is $2.82 or a P/E of only 11.7 compared to historic 13 - 14. Conclusion: BB&T won't be a home run. But it's a Steady Eddie bank "that gives time to wory about your kids and lets you sleep at night" with an attractive income stream compared with alternative equities.
BB&T was also in the Research Reports section. FIG Partners expects shares to trade $39 - $40 in next 9 months. They think the stock could exceed that and they recommend further accumulation of shares by new and existing investors.
Agree. I am a customer of the gas distribution company. This is the perfect company in terms of growth because of the need to replace the pipes. The gas business is projected to be bigger than the electric (distribution + generation). They have also been building new houses again. Not at the pre-2008 rate but are filling in all the subdivisions that had lots left. Once that is done there is plenty of farmland close to the city. Indy is also a midwest hub for shipping (think distribution of on line purchases). New warehouses are being built all the time. Finally this is a takeover candidate. Duke has operations adjacent to VVC and might be interested into acquiring gas assets.
The problem is not necessarily AMGN but the ETF's in which it resides and there are 21. Some are small however XLV (AMGN = 4.5%) trades over 12 million shares per day and IBB (AMGN = 8.3%) trades about 2.25 million per day. So when the market does not like biotechs or in some instances healthcare in general AMGN still gets the #$%$ kicked out of it by being in a bad neighborhood. In addition, this spooks others to dump the stock because they are unaware that the downturn does not necessarily reflect how investors think about AMGN as an individual stock. Only ETFs I have ever owned are commodities and currencies which allows you to trade them without having a commodities broker.
Never trade on the headline news. It always come back to bite you in the #$%$. I see we were down about $3 out of the gate and are now up about $2.50. Someone threw away about $5.50. Wish i was that rich that I could throw away $5.50 per share.